Company
4D Molecular Therapeutics
EmeryvilleBiotechnologyHealth CareMedicalGeneticsTherapeuticsDescription
EMERYVILLE, Calif., Sept. 12, 2023 -- 4D Molecular Therapeutics , a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines, today announced the appointment of Uneek Mehra as Chief Financial & Business Officer of 4DMT. Mr
Quick answer
4DMT Appoints Uneek Mehra as Chief Financial and Business (September 12, 2023). 4D Molecular Therapeutics is based in Emeryville, California, United States.
- What did 4D Molecular Therapeutics announce on September 12, 2023?
- EMERYVILLE, Calif., Sept. 12, 2023 -- 4D Molecular Therapeutics , a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines, today announced the appointment of Uneek Mehra as Chief Financial & Business Officer of 4DMT.
- What does 4D Molecular Therapeutics do?
- 4DMT is a late-stage biotechnology company developing durable, disease-targeted genetic medicines designed to transform treatment paradigms and deliver long-lasting benefits to patients.
- Where is 4D Molecular Therapeutics based?
- 4D Molecular Therapeutics is based in Emeryville, California, United States.
- Which similar companies made leadership changes around the same time?
- Pliant Therapeutics (September 15, 2023), Nanoscope Therapeutics (September 21, 2023), Hansa Biopharma (September 1, 2023) and Imugene (September 1, 2023) also announced leadership changes within 45 days of 4D Molecular Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Genetics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pliant Therapeutics Appoints Minnie Kuo as Chief (September 15, 2023)
- Nanoscope Therapeutics Strengthens Clinical and Regulatory Expertise With Appointment of Samuel Barone, M.D., as Chief Medical Officer (September 21, 2023)
- Hansa Biopharma Names Hitto Kaufmann Chief Scientific Officer (September 1, 2023)
- Imugene appoints Dr John Byon as senior vice president of clinical development (September 1, 2023)
- Strata Oncology Announces Appointment of Goz Alhir as Senior Vice President of Commercialization (September 26, 2023)
- MATI THERAPEUTICS ANNOUNCES PROMOTION OF CHRIS MULLER TO CHIEF OPERATING OFFICER (September 26, 2023)
Who to call at 4D Molecular Therapeutics, and when
A new leader at 4D Molecular Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day 4D Molecular Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at 4D Molecular Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at 4D Molecular Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment 4D Molecular Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
4D Molecular Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.